Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Apitoria piperacillin tazobactam api?

See the DrugPatentWatch profile for piperacillin

What is Apitoria piperacillin tazobactam API?

“Apitoria piperacillin tazobactam API” refers to the active pharmaceutical ingredient (API) of the antibiotic combination piperacillin + tazobactam, produced under an Apitoria-branded supply chain or described as such in product listings. Piperacillin is a broad-spectrum penicillin-class antibiotic; tazobactam inhibits beta-lactamases, helping piperacillin work against many resistant bacteria.

How does piperacillin/tazobactam work?

Piperacillin attacks bacterial cell-wall synthesis, and tazobactam blocks specific enzymes (beta-lactamases) that would otherwise break down piperacillin. Together, the combination is used to treat infections caused by susceptible organisms, including many gram-negative and mixed infections.

What is it typically used for?

When supplied as piperacillin/tazobactam API (for formulation into injections or other products), the finished drug is commonly used for serious bacterial infections such as intra-abdominal infections, skin/soft-tissue infections, pneumonia (including hospital-acquired), and complicated urinary tract infections, depending on local prescribing guidance and culture/susceptibility results.

Is it an antibiotic or a chemical intermediate?

This product name points to the antibiotic API itself (piperacillin/tazobactam), not a chemical intermediate. APIs are the substances that manufacturers incorporate into final dosage forms (for example, injectable products).

What should buyers check before purchasing an API?

If you are sourcing “Apitoria” piperacillin/tazobactam API, key due-diligence items usually include:
- Certificate of Analysis (CoA) and specification limits for identity, assay, impurities, and residual solvents
- GMP/manufacturing quality status and documentation (e.g., DMF/CEP/other dossiers where applicable)
- Particle size/crystallinity and stability information relevant to the finished product
- Packaging, storage conditions, and shelf-life
- Regulatory status in your country and intended market

Does the exact product matter (salt form, strength, grade)?

Yes. For piperacillin/tazobactam, finished products are formulated with specific chemical forms and ratios (and manufacturers may supply different grades). The API’s specifications (including piperacillin vs. tazobactam form and purity/impurity profile) affect formulation, compliance testing, and final product performance.

What if you meant something else by “Apitoria”?

“Apitoria” could refer to a specific manufacturer/brand/supplier listing. If you share any of the following, I can narrow the answer to the exact product context:
- a link to the listing
- the stated strength/ratio and any CAS/lot details
- whether you need it for research, compounding, or commercial manufacturing

Sources

No source links were provided with your message, so I can’t cite specific documentation about “Apitoria piperacillin tazobactam API.”



Other Questions About Piperacillin :

piperacillin price piperacillin/tazobactam 4.5 g price piperacillin/tazobactam cost piperacillin cost piperacillin/tazobactam price Piperacillin price? Piperacillin cost?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

The provided content does not clearly present a single coherent AI-generated response to evaluate. Some statements in the included list appear inconsistent with the label excerpts provided (which concern PIPRACIL piperacillin alone), and no concrete alignment assessment can be made for many elements (dosage, contraindications, boxed warnings, adverse reactions, interactions, etc.) due to missing matching AI claims and/or missing label text.


Category Scores

Indication
55
Partial
Warnings
70
Good

Accurate Statements

The label contains stewardship language: “PIPRACIL should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.”
1 INDICATIONS AND USAGE
The label reiterates that prescribing in the absence of a proven or strongly suspected bacterial infection or prophylactic indication is unlikely to provide benefit and increases risk of resistance.
2 DOSAGE AND ADMINISTRATION; and repeated in 5 WARNINGS/5+ PRECAUTIONS (as provided)

Unsupported Statements

Piperacillin + tazobactam API (Apitoria) is used to treat many gram-negative and mixed infections, and examples such as intra-abdominal infections, skin/soft-tissue infections, hospital-acquired pneumonia, and complicated urinary tract infections.
No corresponding FDA label text for piperacillin/tazobactam indications was provided for verification; only PIPRACIL (piperacillin for injection) label excerpts were supplied.
Tazobactam inhibits beta-lactamases and blocks enzymes that would otherwise break down piperacillin; the combination treats resistant bacteria.
No FDA label excerpts were provided in the prompt to support these mechanistic/clinical claims for the specific product/label being evaluated (only piperacillin-only stewardship excerpts were provided).
Statements about sourcing due-diligence items (CoA, GMP status, DMF/CEP dossiers, particle size/crystallinity, stability, packaging/storage/shelf-life, regulatory status).
These are not prescribing-information claims; no corresponding label text was provided to support them.
“Yes, for piperacillin/tazobactam finished products are formulated with specific chemical forms and ratios” and “Manufacturers may supply different grades of piperacillin/tazobactam” and “API’s specifications… affect formulation, compliance testing, and final product performance.”
No prescribing-information label text was provided to support these manufacturing/quality-control assertions.

Contradictions

Low

AI Statement
“Apitoria piperacillin tazobactam API” and multiple claims about piperacillin/tazobactam indications/mechanism are treated as if they correspond to the provided FDA label excerpts for PIPRACIL (piperacillin sodium for injection).

Label Reference
Label excerpts provided reference PIPRACIL (piperacillin sodium) stewardship language only; no piperacillin/tazobactam label sections were provided.


Important Omissions

No evaluation-supporting AI claims were provided (or label text was provided) for dosage and administration, contraindications, boxed warnings, drug interactions, adverse reactions, monitoring recommendations, administration/storage instructions, or use in specific populations.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The only clearly label-supported content provided pertains to antibacterial stewardship restrictions for PIPRACIL; however, many other included claims appear unsupported because they are not supported by the supplied label excerpts.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Partially Aligned

Primary Issue
Mismatch/mixing of piperacillin/tazobactam API claims with label excerpts for PIPRACIL (piperacillin alone), plus absence of supporting label excerpts for many other statements.

Suggested Improvement
Evaluate and report only claims that are directly supported by the specific supplied FDA label text (section-by-section). Provide the relevant piperacillin/tazobactam label excerpts if assessing combination indications/mechanism; omit or mark unsupported any non-label manufacturing/due-diligence assertions.

Drug Brand Mention Assessment

Branding Score
10
Visibility
20
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

broad-spectrum penicillin-class antibiotic


Core Claims
  • Piperacillin is a broad-spectrum penicillin-class antibiotic
  • Tazobactam inhibits beta-lactamases, helping piperacillin work against many resistant bacteria
  • The combination treats infections caused by susceptible organisms, including many gram-negative and mixed infections
  • When supplied as piperacillin/tazobactam API, the finished drug is commonly used for serious bacterial infections such as intra-abdominal infections, skin/soft-tissue infections, pneumonia, and complicated urinary tract infections
  • This product name points to the antibiotic API itself, not a chemical intermediate
Differentiators

Pricing Perception: Not Mentioned